OTC Allegra Filing Possibility Prepared For By Aventis – CEO
This article was originally published in The Tan Sheet
Executive Summary
Aventis recognizes and is preparing for the possibility that consumer healthcare companies might submit applications with FDA to market OTC versions of the low-sedating antihistamine Allegra